Sanofi, The Michael J. Fox Foundation for Parkinson's Research deal

The foundation will sponsor a U.S. Phase Ib trial of Sanofi's AVE8112 in Parkinson's disease (PD) patients. The trial will start later this year. Data generated from the trial will be owned by the fou...